NEKTAR THERAPEUTICS
Industry: Life Sciences ・ $NKTR on Nasdaq
Insider Sale
+$8,788
-2.66%
Shares
Shares Volume: 6,866 Shares
Average Share Price: $1.28
INSIDER
Zalevsky Jonathan
Chief R&D Officer (Officer)
reported on Aug 20 2024
traded on Aug 19 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 250,804 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $8,128.95 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 17 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $15,698.27 |
| COMPANY PREVIOUS TRADES |